| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
DDX5 |
DDX5, G17P1, HELR, HLR1: Probable ATP-dependent RNA helicase DDX5 |
5.557 |
Evidence |
|
| UNG |
IPI00011069 |
EP300 |
IPI00478752 |
5.557 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
5.557 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
FKBP4 |
FKBP4: FK506-binding protein 4 |
5.557 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
CDK2 |
CDK2: Cell division protein kinase 2 |
5.557 |
Evidence |
|
| SNRP70 |
SNRP70, RNPU1Z, RPU1, U1AP1: U1 small nuclear ribonucleoprotein 70 kDa |
CRKRS |
CRKRS, CRK7, KIAA0904: Cell division cycle 2-related protein kinase 7 |
5.557 |
Evidence |
|
| ITGAV |
ITGAV, MSK8, VNRA: Integrin alpha-V precursor |
DLG1 |
IPI00218729 |
5.557 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PTPN11 |
IPI00298347 |
5.557 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
FKBP1A |
FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A |
5.557 |
Evidence |
|
| OXSR1 |
OXSR1, KIAA1101, OSR1: Serine/threonine-protein kinase OSR1 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
5.557 |
Evidence |
|
| RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
5.557 |
Evidence |
|
| CRSP2 |
MED14, ARC150, CRSP2, CXorf4, DRIP150, EXLM1, RGR1, TRAP170: Mediator of RNA pol |
CDK2 |
CDK2: Cell division protein kinase 2 |
5.557 |
Evidence |
|
| CRSP2 |
MED14, ARC150, CRSP2, CXorf4, DRIP150, EXLM1, RGR1, TRAP170: Mediator of RNA pol |
SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
5.557 |
Evidence |
|
| AKAP8 |
AKAP8, AKAP95: A-kinase anchor protein 8 |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
5.557 |
Evidence |
|
| SGTA |
SGTA, SGT: Small glutamine-rich tetratricopeptide repeat-containing protein A |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
5.557 |
Evidence |
|
| WASPIP |
IPI00552369 |
PTPN11 |
IPI00298347 |
5.557 |
Evidence |
|
| DDX3Y |
DDX3Y, DBY: ATP-dependent RNA helicase DDX3Y |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
5.557 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
5.557 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
STK11 |
STK11, LKB1, PJS: Serine/threonine-protein kinase 11 |
5.557 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
GSR |
GSR, GLUR, GRD1: Glutathione reductase, mitochondrial precursor |
5.557 |
Evidence |
|
| PPP2CA |
PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
PPP2R5A |
PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha |
5.555 |
Evidence |
|
| HCK |
IPI00029769 |
FNBP1 |
IPI00102670 |
5.555 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
KRT6E |
KRT6C, KRT6E: Keratin, type II cytoskeletal 6C |
5.552 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
RAB4A |
IPI00549945 |
5.552 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
KRT6E |
KRT6C, KRT6E: Keratin, type II cytoskeletal 6C |
5.552 |
Evidence |
|